Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 322

1.

Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysis.

Guillou L, Benhattar J, Bonichon F, Gallagher G, Terrier P, Stauffer E, Somerhausen Nde S, Michels JJ, Jundt G, Vince DR, Taylor S, Genevay M, Collin F, Trassard M, Coindre JM.

J Clin Oncol. 2004 Oct 15;22(20):4040-50. Epub 2004 Sep 13.

PMID:
15364967
2.

Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.

Ladanyi M, Antonescu CR, Leung DH, Woodruff JM, Kawai A, Healey JH, Brennan MF, Bridge JA, Neff JR, Barr FG, Goldsmith JD, Brooks JS, Goldblum JR, Ali SZ, Shipley J, Cooper CS, Fisher C, Skytting B, Larsson O.

Cancer Res. 2002 Jan 1;62(1):135-40.

3.

Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan.

Takenaka S, Ueda T, Naka N, Araki N, Hashimoto N, Myoui A, Ozaki T, Nakayama T, Toguchida J, Tanaka K, Iwamoto Y, Matsumine A, Uchida A, Ieguchi M, Kaya M, Wada T, Baba I, Kudawara I, Aoki Y, Yoshikawa H.

Oncol Rep. 2008 Feb;19(2):467-76.

PMID:
18202796
4.

Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcoma.

Sun Y, Sun B, Wang J, Cai W, Zhao X, Zhang S, Hao X.

Cancer Sci. 2009 Jun;100(6):1018-25. doi: 10.1111/j.1349-7006.2009.01134.x. Epub 2009 Mar 25.

5.

SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcoma.

Kawai A, Woodruff J, Healey JH, Brennan MF, Antonescu CR, Ladanyi M.

N Engl J Med. 1998 Jan 15;338(3):153-60.

6.

SYT-SSX fusion genes and prognosis in synovial sarcoma.

Mezzelani A, Mariani L, Tamborini E, Agus V, Riva C, Lo Vullo S, Fabbri A, Stumbo M, Azzarelli A, Casali PG, Gronchi A, Sozzi G, Pierotti MA, Pilotti S.

Br J Cancer. 2001 Nov 16;85(10):1535-9.

7.

The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.

Nilsson G, Skytting B, Xie Y, Brodin B, Perfekt R, Mandahl N, Lundeberg J, Uhlén M, Larsson O.

Cancer Res. 1999 Jul 1;59(13):3180-4.

8.

The classic prognostic factors tumor stage, tumor size, and tumor grade are the strongest predictors of outcome in synovial sarcoma: no role for SSX fusion type or ezrin expression.

ten Heuvel SE, Hoekstra HJ, Bastiaannet E, Suurmeijer AJ.

Appl Immunohistochem Mol Morphol. 2009 May;17(3):189-95. doi: 10.1097/PAI.0b013e31818a6f5c.

PMID:
18997619
9.

Strong association of SYT-SSX fusion type and morphologic epithelial differentiation in synovial sarcoma.

Antonescu CR, Kawai A, Leung DH, Lonardo F, Woodruff JM, Healey JH, Ladanyi M.

Diagn Mol Pathol. 2000 Mar;9(1):1-8.

PMID:
10718206
10.

Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.

Inagaki H, Nagasaka T, Otsuka T, Sugiura E, Nakashima N, Eimoto T.

Mod Pathol. 2000 May;13(5):482-8.

11.

Primary intrathoracic synovial sarcoma: a clinicopathologic study of 40 t(X;18)-positive cases from the French Sarcoma Group and the Mesopath Group.

Bégueret H, Galateau-Salle F, Guillou L, Chetaille B, Brambilla E, Vignaud JM, Terrier P, Groussard O, Coindre JM.

Am J Surg Pathol. 2005 Mar;29(3):339-46.

PMID:
15725802
12.

Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.

Izumi T, Oda Y, Hasegawa T, Nakanishi Y, Kawai A, Sonobe H, Takahira T, Kobayashi C, Yamamoto H, Tamiya S, Hirohashi S, Iwamoto Y, Tsuneyoshi M.

Am J Surg Pathol. 2007 Jan;31(1):85-94.

PMID:
17197923
13.

Molecular diagnosis of synovial sarcoma: RT-PCR detection of SYT-SSX1/2 fusion transcripts in paraffin-embedded tissue.

Tvrdík D, Povýsil C, Svatosová J, Dundr P.

Med Sci Monit. 2005 Mar;11(3):MT1-7.

PMID:
15735574
14.

SYT-SSX fusion genes in synovial sarcoma of the thorax.

Yano M, Toyooka S, Tsukuda K, Dote H, Morimoto Y, Ohata N, Ichimura K, Aoe M, Date H, Shimizu N.

Lung Cancer. 2004 Jun;44(3):391-7. Review.

PMID:
15140553
15.

Analysis of SYT-SSX fusion transcripts and bcl-2 expression and phosphorylation status in synovial sarcoma.

Mancuso T, Mezzelani A, Riva C, Fabbri A, Dal Bo L, Sampietro G, Perego P, Casali P, Zunino F, Sozzi G, Pierotti MA, Pilotti S.

Lab Invest. 2000 Jun;80(6):805-13.

PMID:
10879732
16.

Detection of SYT-SSX fusion transcripts in paraffin-embedded tissues of synovial sarcoma by reverse transcription-polymerase chain reaction.

Wei Y, Wang J, Zhu X, Shi D, Hisaoka M, Hashimoto H.

Chin Med J (Engl). 2002 Jul;115(7):1043-7.

PMID:
12150740
17.

Clinical impact of molecular and cytogenetic findings in synovial sarcoma.

Panagopoulos I, Mertens F, Isaksson M, Limon J, Gustafson P, Skytting B, Akerman M, Sciot R, Dal Cin P, Samson I, Iliszko M, Ryoe J, Dêbiec-Rychter M, Szadowska A, Brosjö O, Larsson O, Rydholm A, Mandahl N.

Genes Chromosomes Cancer. 2001 Aug;31(4):362-72.

PMID:
11433527
18.

Synovial sarcoma. A Scandinavian Sarcoma Group project.

Skytting B.

Acta Orthop Scand Suppl. 2000 Apr;291:1-28.

PMID:
10862210
19.

Primary monophasic synovial sarcoma of the pleura: five cases confirmed by the presence of SYT-SSX fusion transcript.

Aubry MC, Bridge JA, Wickert R, Tazelaar HD.

Am J Surg Pathol. 2001 Jun;25(6):776-81.

PMID:
11395555
20.

Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcript.

Fligman I, Lonardo F, Jhanwar SC, Gerald WL, Woodruff J, Ladanyi M.

Am J Pathol. 1995 Dec;147(6):1592-9.

Supplemental Content

Support Center